10-Q Filing

Cryoport, Inc. CIK: 1124524 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0000950123-11-098497`
Period End Date	20110930
Filing Date	20111114
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	cyrx-20110930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 62 Cash Flow Statement 70

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.95M	USD	Point-in-time
Allowance for doubtful accounts receivable	`AllowanceForDoubtfulAccountsReceivable`	$9.10K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.28M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.75M	USD	Point-in-time
Allowance for doubtful accounts receivable	`AllowanceForDoubtfulAccountsReceivable`	$1.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.63M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$91.17K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Accounts receivable, net of allowances of $1,000 at September 30, 2011 and $9,100 at March 31, 2011, respectively	`AccountsReceivableNetCurrent`	$55.79K	USD	Point-in-time
Accounts receivable, net of allowances of $1,000 at September 30, 2011 and $9,100 at March 31, 2011, respectively	`AccountsReceivableNetCurrent`	$111.39K	USD	Point-in-time
Discount on convertible debentures, current	`DebtInstrumentUnamortizedDiscount`	$197.23K	USD	Point-in-time
Discount on convertible debentures, current	`DebtInstrumentUnamortizedDiscount`	$78.14K	USD	Point-in-time
Inventories	`InventoryNet`	$44.22K	USD	Point-in-time
Inventories	`InventoryNet`	$42.68K	USD	Point-in-time
Discount on convertible debentures, non current	`DiscountOnConvertibleDebenturesNoncurrent`	$8.84K	USD	Point-in-time
Discount on convertible debentures, non current	`DiscountOnConvertibleDebenturesNoncurrent`	-	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$251.32K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$528.04K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.00M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$677.96K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$669.58K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$354.85K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$386.77K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Deposits and other assets	`DepositsAndOtherAssets`	$9.36K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Deposits and other assets	`DepositsAndOtherAssets`	$9.36K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total assets	`Assets`	$6.43M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total assets	`Assets`	$11.03M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	28.13M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.50M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$506.89K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$563.91K	USD	Point-in-time
Accrued compensation and related expenses	`EmployeeRelatedLiabilitiesCurrent`	$409.69K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	28.13M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.50M	shares	Point-in-time
Accrued compensation and related expenses	`EmployeeRelatedLiabilitiesCurrent`	$402.75K	USD	Point-in-time
Current portion of convertible debentures payable, net of discount of $78,138 at September 30, 2011 and $197,226 at March 31, 2011, respectively	`ConvertibleDebtCurrent`	$1.98M	USD	Point-in-time
Current portion of convertible debentures payable, net of discount of $78,138 at September 30, 2011 and $197,226 at March 31, 2011, respectively	`ConvertibleDebtCurrent`	$1.35M	USD	Point-in-time
Line of credit and accrued interest	`LineOfCreditAndAccruedInterest`	-	USD	Point-in-time
Line of credit and accrued interest	`LineOfCreditAndAccruedInterest`	$90.39K	USD	Point-in-time
Current portion of related party notes payable	`NotesPayableRelatedPartiesClassifiedCurrent`	$96.00K	USD	Point-in-time
Current portion of related party notes payable	`NotesPayableRelatedPartiesClassifiedCurrent`	$102.00K	USD	Point-in-time
Derivative liabilities	`DerivativeInstrumentsAndHedgesLiabilities`	$156.50K	USD	Point-in-time
Derivative liabilities	`DerivativeInstrumentsAndHedgesLiabilities`	$107.53K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.24M	USD	Point-in-time
Related party notes payable and accrued interest, net of current portion	`NotesPayableRelatedPartiesNoncurrent`	$1.40M	USD	Point-in-time
Related party notes payable and accrued interest, net of current portion	`NotesPayableRelatedPartiesNoncurrent`	$1.42M	USD	Point-in-time
Convertible debentures payable, net of current portion and discount of $0 at September 30, 2011 and $8,842 at March 31, 2011, respectively	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Convertible debentures payable, net of current portion and discount of $0 at September 30, 2011 and $8,842 at March 31, 2011, respectively	`ConvertibleDebtNoncurrent`	$421.73K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.08M	USD	Point-in-time
Preferred stock, $0.001 par value, 2,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 2,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 28,133,074 and 27,504,604 shares issued and outstanding at September 30, 2011 and March 31, 2011, respectively	`CommonStockValue`	$28.13K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 28,133,074 and 27,504,604 shares issued and outstanding at September 30, 2011 and March 31, 2011, respectively	`CommonStockValue`	$27.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$58.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$58.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-56.18M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.03M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.43M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`SalesRevenueNet`	$275.87K	USD	2 Qtrs
Net revenues	`SalesRevenueNet`	$110.71K	USD	1 Quarter
Net revenues	`SalesRevenueNet`	$234.46K	USD	2 Qtrs
Net revenues	`SalesRevenueNet`	$124.41K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$363.55K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$772.75K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$378.22K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$717.83K	USD	2 Qtrs
Gross loss	`GrossProfit`	$-496.88K	USD	2 Qtrs
Gross loss	`GrossProfit`	$-252.84K	USD	1 Quarter
Gross loss	`GrossProfit`	$-253.81K	USD	1 Quarter
Gross loss	`GrossProfit`	$-483.37K	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.06M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.11M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.19M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.56M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$225.94K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$124.70K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$114.51K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$236.63K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.42M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.23M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.29M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.48M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.90M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.94M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.79M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$7.35K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$11.81K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$3.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$4.96K	USD	1 Quarter
Interest expense	`InterestExpense`	$157.45K	USD	1 Quarter
Interest expense	`InterestExpense`	$107.76K	USD	1 Quarter
Interest expense	`InterestExpense`	$241.07K	USD	2 Qtrs
Interest expense	`InterestExpense`	$296.16K	USD	2 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$126.34K	USD	1 Quarter
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$48.97K	USD	2 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$14.69K	USD	1 Quarter
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$242.87K	USD	2 Qtrs
Total other expense, net	`OtherNonoperatingIncomeExpense`	$-27.20K	USD	1 Quarter
Total other expense, net	`OtherNonoperatingIncomeExpense`	$-88.11K	USD	1 Quarter
Total other expense, net	`OtherNonoperatingIncomeExpense`	$-45.94K	USD	2 Qtrs
Total other expense, net	`OtherNonoperatingIncomeExpense`	$-180.28K	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.84M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.08M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.51M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.03M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$1.60K	USD	2 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$1.60K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.84M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.08M	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	2 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	2 Qtrs
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	27.83M	shares	2 Qtrs
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.27M	shares	1 Quarter
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	27.97M	shares	1 Quarter
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.21M	shares	2 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.84M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.08M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$109.70K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$162.05K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$127.93K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$250.48K	USD	2 Qtrs
Fair value of stock options and warrants issued to consultants, employees and directors	`FairValueOfStockOptionsAndWarrantsIssuedToConsultantsEmployeesAndDirectors`	$-339.44K	USD	2 Qtrs
Fair value of stock options and warrants issued to consultants, employees and directors	`FairValueOfStockOptionsAndWarrantsIssuedToConsultantsEmployeesAndDirectors`	$-370.54K	USD	2 Qtrs
Change in fair value of derivative instruments	`UnrealizedGainLossOnDerivatives`	$126.34K	USD	1 Quarter
Change in fair value of derivative instruments	`UnrealizedGainLossOnDerivatives`	$48.97K	USD	2 Qtrs
Change in fair value of derivative instruments	`UnrealizedGainLossOnDerivatives`	$14.69K	USD	1 Quarter
Change in fair value of derivative instruments	`UnrealizedGainLossOnDerivatives`	$242.87K	USD	2 Qtrs
Loss on disposal of Cryogenic shippers	`LossOnDisposalOfCryogenicShippers`	$-3.51K	USD	2 Qtrs
Interest accrued on restricted cash	`InterestAccruedOnRestrictedCash`	$274.00	USD	2 Qtrs
Interest accrued on restricted cash	`InterestAccruedOnRestrictedCash`	$454.00	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-22.10K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$55.59K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.54K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-125.34K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-40.70K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-84.61K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$178.75K	USD	2 Qtrs
Accrued compensation and related expenses	`IncreaseDecreaseInAccruedCompensationAndRelatedExpense`	$-138.57K	USD	2 Qtrs
Accrued compensation and related expenses	`IncreaseDecreaseInAccruedCompensationAndRelatedExpense`	$-6.95K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$29.59K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$24.38K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.19M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.23M	USD	2 Qtrs
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$73.94K	USD	2 Qtrs
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$79.55K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$122.81K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$271.08K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-202.35K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-345.02K	USD	2 Qtrs
Repayments of convertible debentures payable	`RepaymentsOfConvertibleDebenturesPayable`	$1.18M	USD	2 Qtrs
Payment of deferred financing costs	`PaymentsOfFinancingCosts`	$158.27K	USD	2 Qtrs
Payment of deferred financing costs	`PaymentsOfFinancingCosts`	$273.80K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$456.13K	USD	2 Qtrs
Repayments of related party notes payable	`RepaymentsOfRelatedPartyNotesPayable`	$60.00K	USD	2 Qtrs
Repayments of related party notes payable	`RepaymentsOfRelatedPartyNotesPayable`	$54.00K	USD	2 Qtrs
Proceeds from private placement of common stock, net of cash paid for issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$3.03M	USD	2 Qtrs
Restricted cash-investor funds	`RestrictedCashInvestorFunds`	$255.00K	USD	2 Qtrs
Deposits from investors	`DepositsFromInvestors`	$255.00K	USD	2 Qtrs
Payment on line of credit	`RepaymentsOfLinesOfCredit`	$90.00K	USD	2 Qtrs
Proceeds from release of restricted cash	`ProceedsFromRepaymentsOfRestrictedCashFinancingActivities`	$91.44K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-931.32K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.69M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-4.32M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$115.86K	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.95M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$9.28M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.75M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.63M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.95M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$9.28M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.75M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.63M	USD	Point-in-time
Interest	`InterestPaid`	$88.76K	USD	2 Qtrs
Interest	`InterestPaid`	$15.10K	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	$1.60K	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	$1.60K	USD	2 Qtrs
Deferred financing costs in connection with equity financings	`DeferredFinancingCostsInConnectionWithEquityFinancings`	$46.46K	USD	2 Qtrs
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	$36.00	USD	2 Qtrs
Deferred financing costs offset against proceeds in additional paid-in capital	`DeferredFinancingCostsOffsetAgainstProceedsInAdditionalPaidInCapital`	$25.80K	USD	2 Qtrs
Fair value of options issued to employee in lieu of cash bonus	`FairValueOfOptionsIssuedToEmployeeInLieuOfCashBonus`	$216.00K	USD	2 Qtrs
Reduction of accrued offering costs in connection with February 2010 financing	`ReductionOfAccruedOfferingCostsInConnectionWithSpecificPeriodFinancing`	$29.07K	USD	2 Qtrs
Estimated fair value of shares issued for services	`EstimatedFairValueOfSharesIssuedForServices`	$24.00K	USD	2 Qtrs
Reclassification of fixed assets to inventory	`ReclassificationOfFixedAssetsToInventory`	$60.23K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.